SCHEMBL3847232

SCHEMBL3847232

CC1CN1c1ncnc2ccc(-c3c[nH]nc3-c3ccc(F)cc3)cc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 15/20 0.45
CYP3A4 P08684 15/20 0.45
CYP2C19 P33261 13/20 0.45
ALDH1A1 P00352 12/20 0.45
CLK4 Q9HAZ1 10/20 0.45
USP2 O75604 5/20 0.45
LMNA P02545 11/20 0.44
TSHR P16473 9/20 0.44
HIF1A Q16665 7/20 0.44
CYP2D6 P10635 7/20 0.44
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
HPGD P15428 5/20 0.44
KDM4E B2RXH2 4/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
MAPK1 P28482 7/20 0.43
TP53 P04637 3/20 0.43
HSD17B10 Q99714 5/20 0.39
TDP1 Q9NUW8 1/20 0.39
MAP4K4 O95819 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3854694 0.84 CYP1A2 (0.41) CYP1A2CYP3A4CYP2C19ALDH1A1CLK4
SCHEMBL3846993 0.84 CYP1A2 (0.44) CYP1A2CYP3A4CYP2C19ALDH1A1CLK4
SCHEMBL3848419 0.82 CYP3A4 (0.63) CYP1A2CYP3A4CYP2C19ALDH1A1CLK4
SCHEMBL3849667 0.81 CYP3A4 (0.50) CYP1A2CYP3A4CYP2C19ALDH1A1CLK4
SCHEMBL3847688 0.80 CYP3A4 (0.42) CYP1A2CYP3A4CYP2C19ALDH1A1CLK4
SCHEMBL3850556 0.80 LRRK2 (0.52) CYP1A2CYP3A4CYP2C19ALDH1A1CLK4
Hydrochloric Acid SCHEMBL3849344 0.80 MAP4K4 (0.46) CYP1A2CYP3A4CYP2C19ALDH1A1CLK4
SCHEMBL3848700 0.80 CYP3A4 (0.48) CYP1A2CYP3A4CYP2C19ALDH1A1CLK4
SCHEMBL3845114 0.80 CYP3A4 (0.52) CYP1A2CYP3A4CYP2C19ALDH1A1CLK4
SCHEMBL3844703 0.78 CYP3A4 (0.47) CYP1A2CYP3A4CYP2C19ALDH1A1CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed